INDUSTRY ACADEMIC COOPERATION FOUNDATION; HALLYM UNIVERSITY
发明人:
CHOI, SU YOUNGKR,최수영,PARK, JIN SEOKR,박진서,HAN, KYU HYUNGKR,한규형,CHO, YOON SHINKR,조윤신,UM, WON SIKKR,음원식,CHO, SUNG WOOKR,조성우,KIM, DUK SOOKR,김덕수,KIM, HYOUNG CHUNKR,김형춘,SHIN, EUN JOOKR,신은주,KIM, DAE WONKR,김대
申请号：
KR1020140015225
公开号：
KR1020150094210A
申请日:
2014.02.11
申请国别(地区):
KR
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing and treating diabetes. The pharmaceutical composition contains peroxiredoxin-2 fusion proteins which have a protein transport domain covalently bonded to either or both of the N-terminal and the C-terminal of the peroxiredoxin-2 proteins.COPYRIGHT KIPO 2015본 발명은 퍼옥시레독신 2 단백질의 N 말단 및 C 말단 중 어느 한 곳 이상에 단백질 수송도메인이 공유결합된 퍼옥시레독신 2 융합단백질을 함유하는 당뇨병 예방 및 치료용 약학 조성물에 관한 것이다.
